Cargando…

Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report

Mesenchymal chondrosarcoma is a rare and aggressive sarcoma subtype with high risk for distant metastases and poor prognosis. Currently NCCN- and ESMO-Guidelines recommend using Ewing sarcoma protocols as standard treatment. Nevertheless, in localized disease overall 5-year survival rates are below...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blum, Veronika, Andrei, Vanghelita, Ameline, Baptiste, Hofer, Silvia, Fuchs, Bruno, Strobel, Klaus, Allemann, Anna, Bode, Beata, Baumhoer, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791217/ https://www.ncbi.nlm.nih.gov/pubmed/36578930 http://dx.doi.org/10.3389/fonc.2022.1086677

Ejemplares similares

Update of Key Clinical, Histological and Molecular Features of Malignant Bone Tumours Arising in the Craniofacial Skeleton
por: Haefliger, Simon, et al.
Publicado: (2022)

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Cabozantinib for progressive metastatic medullary thyroid cancer: a review
por: Colombo, Joshua R, et al.
Publicado: (2014)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)

Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response
por: Singh, Amisha, et al.
Publicado: (2022)

Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature
por: Kapur, Sakshi, et al.
Publicado: (2014)

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential
por: Bersanelli, Melissa, et al.
Publicado: (2017)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021)

Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
por: Krens, Stefanie D., et al.
Publicado: (2022)

Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
por: Vano, Yann‐Alexandre, et al.
Publicado: (2022)

Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
por: Colomba, Emeline, et al.
Publicado: (2022)

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
por: Thouvenin, Jonathan, et al.
Publicado: (2022)

Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer
por: Kumar, Shreya, et al.
Publicado: (2023)

DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics
por: Guimarães, Letícia Martins, et al.
Publicado: (2023)

Extraskeletal mesenchymal chondrosarcoma arising in adductor magnus with metastatic foci
por: Hunter, Kyle, et al.
Publicado: (2015)

Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study
por: Malcherczyk, Dominik, et al.
Publicado: (2018)

Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
por: Ameline, Baptiste, et al.
Publicado: (2020)

Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma
por: Wiecek, Witold, et al.
Publicado: (2016)

Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
por: Tansir, Ghazal, et al.
Publicado: (2020)

Surgical treatment of metastatic mesenchymal chondrosarcoma to the spine: A case report
por: Liu, Shuzhong, et al.
Publicado: (2020)

Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma
por: Uche, An, et al.
Publicado: (2019)

Recurrent metastatic clear cell renal carcinoma with sarcomatoid dedifferentiation treated with surgery and Cabozantinib
por: Boustany, Johnny, et al.
Publicado: (2020)

Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy
por: Sidlik Muskatel, Rakefet, et al.
Publicado: (2022)

Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
por: Jones, Robin L., et al.
Publicado: (2017)

The impact of biopsy sampling errors and the quality of surgical margins on local recurrence and survival in chondrosarcoma
por: Hodel, Sandro, et al.
Publicado: (2018)

Mesenchymal chondrosarcoma of kidney
por: Tyagi, Ruchita, et al.
Publicado: (2014)

Mesenchymal chondrosarcoma of mandible
por: Majumdar, Sumit, et al.
Publicado: (2016)

Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone
por: Yu, Kai-Jie, et al.
Publicado: (2017)

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
por: Daud, Adil, et al.
Publicado: (2017)

Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma(1)
por: Sharma, Akanksha, et al.
Publicado: (2022)

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma
por: Kessler, Elizabeth R., et al.
Publicado: (2023)

Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma
por: Sharma, Akanksha, et al.
Publicado: (2023)

Development of cabozantinib for the treatment of prostate cancer
por: Vaishampayan, Ulka N
Publicado: (2014)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Cabozantinib and apixaban: an hitherto unreported interaction
por: Santini, Daniele, et al.
Publicado: (2019)

DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Barenboim, Maxim, et al.
Publicado: (2021)

Multiple or metastatic clear cell chondrosarcoma: a case report
por: Manfrini, Marco, et al.
Publicado: (2014)

Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis
por: Wang, Zhan, et al.
Publicado: (2019)

Metastatic Dedifferentiated Chondrosarcoma to Thyroid Gland: A Case Report
por: Aladily, Tariq N., et al.
Publicado: (2021)

Metastatic extraskeletal myxoid chondrosarcoma presenting as a forehead mass
por: Tan, Kendra W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3enavr21qb53oa3a28ihv3eoq